PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
about
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancerMolecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsLncRNAs in pancreatic cancerImmunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerVirus encoded circulatory miRNAs for early detection of prostate cancerDiagnosis of prostate cancer via nanotechnological approachPotential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelUrinary biomarkers for prostate cancerNovel RNA markers in prostate cancer: functional considerations and clinical translationMicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancerA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialProstate cancer biomarkers: Are we hitting the mark?Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaProstate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic diseaseA four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Novel diagnostic biomarkers for prostate cancer.Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome.Active surveillance in men with low-risk prostate cancer: current and future challenges.Can urinary PCA3 supplement PSA in the early detection of prostate cancer?Progensa PCA3 test for prostate cancer detection.DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.Genomic profiling screens small molecules of metastatic prostate carcinoma.Personalized management in low-risk prostate cancer: the role of biomarkers.Role of active surveillance in the management of localized prostate cancer.Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewApproaches to uncovering cancer diagnostic and prognostic molecular signaturesPerformance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonographyBiomarkers in prostate cancer surveillance and screening: past, present, and future.Markers for detection of prostate cancer.Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.Urine markers in monitoring for prostate cancer.
P2860
Q24569630-7BD6C675-82DA-4B42-A352-1540A0394702Q24629083-FDCD5903-C952-4F92-BB59-8E9D69793E2EQ26739965-8737C57E-8E93-473D-8C09-7AA24E70B4B9Q26767044-12988908-711C-4513-A382-69FB6B4307C3Q26776424-BFD03FB3-7C95-4539-BCF1-2B32ED749F20Q26777322-9D255FD7-E8FB-4683-A3AB-5DECAB62F152Q26784517-3B23EDFC-BC2E-4F8F-8955-CBBE7D4012F9Q27001399-A81147CA-4424-4673-A79A-0A34CE6222E3Q27009110-875B37A9-B1B8-4D7D-854B-FDE9A7A5D1C3Q27021174-8E16B97F-B85D-4990-8B4E-D1B4F2C4062AQ27022048-8D144A6D-529C-40BC-9BB7-BE03D569FF31Q27022638-F8F5E979-4363-4042-8535-357B7ABEE893Q28071654-926F76BE-0076-4437-AA8A-7B98B5E3924EQ28085419-94B17DF1-B6DE-4D02-B754-7B3681BED350Q30422070-F11AA556-520B-4DD0-B538-44DF84848F28Q33449075-481B82F1-FF41-4E28-9EE9-6965EABEFB91Q33642692-F99EBF8E-FEFA-4D15-A3FE-73583C5B95A7Q34014559-C21D87DA-49C8-450B-B1F3-4FA6B9191296Q34231678-07F3084A-D730-4F63-ABF5-0D7207234784Q34296258-9BDE9F6D-2E8F-496B-90E8-26065C8F3C6EQ34448113-B47C0066-A63D-4EAF-8B38-24912DC4FACEQ34692263-F66B67FB-1793-4500-A810-12800A9CB2B5Q34692442-86908EB3-2846-4878-A38D-A0F3A0A2CC86Q34694198-6048E550-D1F2-40A5-A4D0-7A4D33741ABBQ34984413-6EBD48B7-C7D1-4BD9-8BF7-D9DDE6C1CD00Q35022732-B8DED81B-7D32-4EC4-A9DA-A508D25994AFQ35251546-D2CEEA03-9B60-4505-9C17-BC98D87F108FQ35535776-130DCE1A-C5A7-4CDE-8BB5-A481597541ACQ35944324-D79F4228-238D-49DE-8AA2-CA857CBF6FC4Q36495701-B82FEF46-3A74-42AE-9832-357516EBF389Q36520452-55A26594-5A46-4FB4-935A-F373E5ACAC2DQ36886346-B870F25D-29E3-4D7F-96E4-2DACAFE41BA7Q36979944-876A749C-DBA1-463B-A6BF-B4CDE997F493Q36997737-94B17869-F0A0-4ED1-BDAF-CECC1861550CQ37113204-7ED931CA-0F44-4BAB-BC36-833D8CA89264Q37300931-A6051B6A-ACF5-45E7-BAA1-A3A452AEB1A0Q37328403-D8E25D80-43A1-4688-A9E1-AE1E370E2954Q37381526-6044C72B-5FB1-4635-83ED-5304F53DE557Q37507776-894D9F3D-373C-45E1-8133-6B14A45AF5F5Q37571461-662F8E72-6F01-4F5E-BFAB-7657A656FF51
P2860
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@ast
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@en
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@nl
type
label
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@ast
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@en
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@nl
prefLabel
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@ast
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@en
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@nl
P2093
P1433
P1476
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
@en
P2093
Anthony T Cancio
Harry Rittenhouse
Ina Lim Deras
Jack Groskopf
Jeannette Mathis
Leonard S Marks
Marie Desaulniers
Sheila M J Aubin
William J Ellis
P304
P356
10.1016/J.UROLOGY.2006.12.014
P407
P577
2007-03-01T00:00:00Z